Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
August 2017
132
About the Report
About the Report
Australia Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices
Summary
GlobalData's new report, "Australia Drug Delivery Devices Market Outlook to 2023", provides key market data on the Australia Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.
Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.
2016 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the Australia Drug Delivery Devices market.
Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.
Reasons to buy
Develop business strategies by identifying the key market categories poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.
Products
Products
Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd
Companies
Teleflex Inc
GlaxoSmithKline Plc
AstraZeneca Plc
Becton Dickinson and Co
Boehringer Ingelheim GmbH
Baxter International Inc
Fresenius Kabi AG
Pfizer Inc
B. Braun Melsungen AG
Smiths Medical
Merck & Co Inc
Hospira Inc
Terumo Corp
Nipro Corp
Medtronic plc
Table of Contents
Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 What Is This Report About? 7
2.2 Drug Delivery Devices Market Segmentation 7
2.3 Definitions of Markets Covered in the Report 8
3 Drug Delivery Devices Market, Australia 11
3.1 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2023 11
3.2 Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
3.3 Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
3.4 Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
3.5 Drug Delivery Devices Market, Australia, Revenue ($m), 2009-2016 16
3.6 Drug Delivery Devices Market, Australia, Revenue ($m), 2016-2023 18
3.7 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
3.8 Drug Delivery Devices Market, Australia, Volume (Units), 2009-2016 22
3.9 Drug Delivery Devices Market, Australia, Volume (Units), 2016-2023 24
3.10 Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), 2016 26
4 Central Venous Catheters Market, Australia 28
4.1 Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
4.2 Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
4.3 Central Venous Catheters Market, Australia, Revenue ($m), 2009-2016 30
4.4 Central Venous Catheters Market, Australia, Revenue ($m), 2016-2023 32
4.5 Central Venous Catheters Market, Australia, Volume (Units), 2009-2016 34
4.6 Central Venous Catheters Market, Australia, Volume (Units), 2016-2023 36
4.7 Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), 2015-2016 38
4.8 Central Venous Catheters Market, Australia, Company Share by Revenue ($m), 2016 39
5 Infusion Systems Market, Australia 41
5.1 Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
5.2 Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
5.3 Infusion Systems Market, Australia, Revenue ($m), 2009-2016 43
5.4 Infusion Systems Market, Australia, Revenue ($m), 2016-2023 45
5.4.1 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 47
5.4.2 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2009-2016 49
5.4.3 Ambulatory Infusion Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 51
5.4.4 Syringe Pumps Market, Australia, Revenue ($m), by Segment, 2016-2023 53
5.5 Infusion Systems Market, Australia, Volume (Units), 2009-2016 55
5.6 Infusion Systems Market, Australia, Volume (Units), 2016-2023 57
5.6.1 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 59
5.6.2 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2009-2016 61
5.6.3 Ambulatory Infusion Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 63
5.6.4 Syringe Pumps Market, Australia, Volume (Units), by Segment, 2016-2023 65
5.7 Infusion Systems Market, Australia, Distribution Share by Revenue ($m), 2015-2016 67
5.8 Infusion Systems Market, Australia, Company Share by Revenue ($m), 2016 68
6 Needle Free Injections Market, Australia 70
6.1 Needle Free Injections Market, Australia, Revenue ($m), 2009-2016 70
6.2 Needle Free Injections Market, Australia, Revenue ($m), 2016-2023 71
6.3 Needle Free Injections Market, Australia, Volume (Units), 2009-2016 72
6.4 Needle Free Injections Market, Australia, Volume (Units), 2016-2023 73
6.5 Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), 2015-2016 74
6.6 Needle Free Injections Market, Australia, Company Share by Revenue ($m), 2016 75
7 Metered Dose Inhaler Devices Market, Australia 77
7.1 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2009-2016 77
7.2 Metered Dose Inhaler Devices Market, Australia, Revenue ($m), 2016-2023 78
7.3 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2009-2016 79
7.4 Metered Dose Inhaler Devices Market, Australia, Volume (Units), 2016-2023 80
7.5 Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), 2015-2016 81
7.6 Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), 2016 82
8 Overview of Key Companies in Australia, Drug Delivery Devices Market 84
8.1 Teleflex Inc 84
8.1.1 Company Overview 84
8.2 GlaxoSmithKline Plc 84
8.2.1 Company Overview 84
8.3 AstraZeneca Plc 84
8.3.1 Company Overview 84
8.4 Becton Dickinson and Co 84
8.4.1 Company Overview 84
8.5 Boehringer Ingelheim GmbH 85
8.5.1 Company Overview 85
8.6 Baxter International Inc 85
8.6.1 Company Overview 85
8.7 Fresenius Kabi AG 85
8.7.1 Company Overview 85
8.8 Pfizer Inc 86
8.8.1 Company Overview 86
8.9 B. Braun Melsungen AG 86
8.9.1 Company Overview 86
8.10 Smiths Medical 86
8.10.1 Company Overview 86
8.11 Merck & Co Inc 87
8.11.1 Company Overview 87
8.12 Hospira Inc 87
8.12.1 Company Overview 87
8.13 Terumo Corp 87
8.13.1 Company Overview 87
8.14 Nipro Corp 87
8.14.1 Company Overview 87
8.15 Medtronic plc 88
8.19.1 Company Overview 88
9 Drug Delivery Devices Market Pipeline Products 89
10 Financial Deals Landscape 94
10.1 Asset Transactions 94
10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
10.2 Debt Offerings 96
10.2.1 Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
10.3 Equity Offerings 97
10.3.1 Suda Raises USD1.1 Million in Private Placement of Shares 97
10.3.2 Admedus Raises USD7.5 Million in Private Placement of Shares 99
10.3.3 Admedus Raises USD4 Million in Rights Offering of Shares 100
10.4 Partnerships 101
10.4.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
10.4.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
10.4.3 Pfizer Terminates its Licensing Agreement with pSivida 104
10.4.4 Bayer Enters into Licensing Agreement with DelSiTech 105
10.4.5 BioCorRx Enters into Licensing Agreement with Therakine 106
11 Recent Developments 107
11.1 Corporate Communications 107
11.1.1 Jun 09, 2017: Admedus Appoints David St. Denis as Chief Operating Officer 107
11.1.2 May 23, 2017: Analytica: Appointment of Dr. Peter B. Corr as Director 107
11.1.3 Apr 21, 2017: Phosphagenics Announces Transition of Chairman of the Board 108
11.1.4 Apr 04, 2017: GSK responds to Cyclone Debbie 109
11.1.5 Mar 15, 2017: Admedus Appoints Wayne Paterson As Chief Executive Officer 109
11.1.6 Mar 14, 2017: Admedus Appoints John Seaberg As Chairman 110
11.1.7 Dec 12, 2016: Cologuard Available to Humana Members as In-Network Colon Cancer Screening Option 111
11.1.8 Dec 08, 2016: Acrux Announces Director Resignation 112
11.1.9 Oct 17, 2016: Medrobotics Corporation Receives Expanded CE Mark for Flex Robotic System 112
11.1.10 Sep 25, 2016: Admedus Strengthens Management Team 113
11.1.11 Sep 15, 2016: Anne Belcher to succeed Geoff McDonald as GSK Australia general manager 113
11.1.12 Aug 26, 2016: Admedus Appoints New Chief Financial Officer 114
11.2 Financial Announcements 114
11.2.1 May 02, 2017: GSK Australia Reports 2016 results to ASIC 114
11.2.2 Apr 28, 2017: Clinuvel Pharmaceuticals: Appendix 4C-Quarterly report 115
11.2.3 Feb 28, 2017: Phosphagenics Full Year Financial Results 116
11.2.4 Feb 24, 2017: Admedus Announces Half Yearly Report 117
11.2.5 Feb 23, 2017: ITL Profit Doubles In Half Year 2016/2017 Results 118
11.2.6 Feb 20, 2017: Medical Developments Reports Revenue Of AUD8m In H1 Fiscal 2017 118
11.2.7 Oct 31, 2016: Suda: Appendix 4C For First Quarter Fy 2017 119
11.2.8 Oct 28, 2016: Analytica: Appendix 4C-Quarterly Cash Flow Report 119
11.2.9 Aug 31, 2016: Analytica Announces 2016 Full Year Results 119
11.2.10 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016 120
11.2.11 Jul 20, 2016: Admedus Announces Financial Report 121
11.3 Legal And Regulatory 122
11.3.1 May 29, 2017: Phosphagenic-Mylan Arbitration Update-expert report on quantum of damages claimed filed 122
11.3.2 Jan 20, 2017: Change of Registered Office and Principal Place of Business 122
11.3.3 Sep 09, 2016: Admedus Announces Settlement Of Federal Court Proceedings 122
11.4 Other Significant Developments 123
11.4.1 Apr 26, 2017: Axiron Net Sales, quarter to March 2017 123
11.4.2 Apr 13, 2017: PreveCeutical Signs Letter of Intent for Research & Development for Cannabinoid and Diabetes Products with UniQuest 123
11.4.3 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 124
11.4.4 Jan 31, 2017: Analytica Releases Quarterly Cash Flow Report 125
11.4.5 Dec 23, 2016: Admedus Finishes Year With Growing Revenue After Completing Code Red Review 125
11.4.6 Oct 28, 2016: Starpharma Quarterly Cashflow Report 126
11.5 Product News 127
11.5.1 Oct 26, 2016: Starpharma to present at US Drug Delivery Conference 127
12 Appendix 128
12.1 Research Methodology 129
12.1.1 Coverage 129
12.1.2 Secondary Research 129
12.1.3 Primary Research 130
12.1.4 Company Share Analysis 130
12.1.5 Distribution Share Analysis 130
12.1.6 Benchmarking 131
12.2 GlobalData Consulting 131
12.3 Contact Us 132
12.4 Disclaimer 132
List of Figure
1.2 List of Figures
Figure 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 11
Figure 2: Drug Delivery Devices Market, Australia, Revenue Mix ($m), 2016 13
Figure 3: Drug Delivery Devices Market, Australia, Category Contribution (%), 2016 14
Figure 4: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
Figure 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 16
Figure 6: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 18
Figure 7: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 20
Figure 8: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 22
Figure 9: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 24
Figure 10: Drug Delivery Devices Market, Australia, Company Share (%) 2016 26
Figure 11: Central Venous Catheters Market, Australia, Revenue Mix ($m), 2016 28
Figure 12: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
Figure 13: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 30
Figure 14: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 32
Figure 15: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 34
Figure 16: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 36
Figure 17: Central Venous Catheters Market, Australia, Company Share (%) 2016 39
Figure 18: Infusion Systems Market, Australia, Revenue Mix ($m), 2016 41
Figure 19: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
Figure 20: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 43
Figure 21: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 45
Figure 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 47
Figure 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 49
Figure 24: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 51
Figure 25: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 53
Figure 26: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 55
Figure 27: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 57
Figure 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 59
Figure 29: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 61
Figure 30: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 63
Figure 31: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 65
Figure 32: Infusion Systems Market, Australia, Company Share (%) 2016 68
Figure 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
Figure 34: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Figure 35: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
Figure 36: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
Figure 37: Needle Free Injections Market, Australia, Company Share (%) 2016 75
Figure 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
Figure 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Figure 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
Figure 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
Figure 42: Metered Dose Inhaler Devices Market, Australia, Company Share (%) 2016 82
List of Table
1.1 List of Tables
Table 1: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, 2009-2023 12
Table 2: Drug Delivery Devices Market, Australia, Category Contribution by Revenue ($m), 2016 14
Table 3: Drug Delivery Devices Market, Australia, Category Comparison by Revenue ($m), 2009-2023 15
Table 4: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 5: Drug Delivery Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 19
Table 6: Drug Delivery Devices Market, Australia, Volume (Units), 2009-2023 21
Table 7: Drug Delivery Devices Market, Australia, Volume (Units), Historic, 2009-2016 23
Table 8: Drug Delivery Devices Market, Australia, Volume (Units), Forecast, 2016-2023 25
Table 9: Drug Delivery Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 27
Table 10: Central Venous Catheters Market, Australia, Segment Contribution (%), 2016 29
Table 11: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 31
Table 12: Central Venous Catheters Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 33
Table 13: Central Venous Catheters Market, Australia, Volume (Units), Historic, 2009-2016 35
Table 14: Central Venous Catheters Market, Australia, Volume (Units), Forecast, 2016-2023 37
Table 15: Central Venous Catheters Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 38
Table 16: Central Venous Catheters Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 40
Table 17: Infusion Systems Market, Australia, Segment Contribution (%), 2016 42
Table 18: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 44
Table 19: Infusion Systems Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 46
Table 20: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 48
Table 21: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 50
Table 22: Ambulatory Infusion Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 52
Table 23: Syringe Pumps Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 54
Table 24: Infusion Systems Market, Australia, Volume (Units), Historic, 2009-2016 56
Table 25: Infusion Systems Market, Australia, Volume (Units), Forecast, 2016-2023 58
Table 26: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Historic, 2009-2016 60
Table 27: Syringe Pumps Market, Australia, Volume (Units), Historic, 2009-2016 62
Table 28: Ambulatory Infusion Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 64
Table 29: Syringe Pumps Market, Australia, Volume (Units), Forecast, 2016-2023 66
Table 30: Infusion Systems Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 67
Table 31: Infusion Systems Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 69
Table 32: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 70
Table 33: Needle Free Injections Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 71
Table 34: Needle Free Injections Market, Australia, Volume (Units), Historic, 2009-2016 72
Table 35: Needle Free Injections Market, Australia, Volume (Units), Forecast, 2016-2023 73
Table 36: Needle Free Injections Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 74
Table 37: Needle Free Injections Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 76
Table 38: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Historic, 2009-2016 77
Table 39: Metered Dose Inhaler Devices Market, Australia, Revenue ($m), USD Constant, Forecast, 2016-2023 78
Table 40: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Historic, 2009-2016 79
Table 41: Metered Dose Inhaler Devices Market, Australia, Volume (Units), Forecast, 2016-2023 80
Table 42: Metered Dose Inhaler Devices Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2015-2016 81
Table 43: Metered Dose Inhaler Devices Market, Australia, Company Share by Revenue ($m), USD Constant, 2016 83
Table 44: Drug Delivery Devices Market Pipeline Products 89
Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94
Table 46: Suda to Raise USD0.6 Million in Public Offering of 8% Convertible Notes Due March 2019 96
Table 47: Suda Raises USD1.1 Million in Private Placement of Shares 97
Table 48: Admedus Raises USD7.5 Million in Private Placement of Shares 99
Table 49: Admedus Raises USD4 Million in Rights Offering of Shares 100
Table 50: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 101
Table 51: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 102
Table 52: Pfizer Terminates its Licensing Agreement with pSivida 104
Table 53: Bayer Enters into Licensing Agreement with DelSiTech 105
Table 54: BioCorRx Enters into Licensing Agreement with Therakine 106
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.